Which units do you need for a CPP41419 role in New South Wales?
Compare retained New South Wales training requirements with the CPP41419 award, and see where an exact unit map still needs confirmation.
Which codes form the assistant-agent package?
NSW Fair Trading lists CPPREP4001 Prepare for professional practice in real estate; CPPREP4002 Access and interpret ethical practice in real estate; CPPREP4003 Access and interpret legislation in real estate; CPPREP4004 Establish marketing and communication profiles in real estate; and CPPREP4005 Prepare to work with real estate trust accounts. This five-unit package is an entry step, not the full 18-unit CPP41419 award.
NSW — Assistant agent certificate of registration (source record 2026-10-08) · National Training Register — CPP41419 Release 3 unit grid (source record 2026-10-13)
How does the unrestricted Class 2 selection differ?
The usual unrestricted Class 2 mix recorded in the NSW guide is five core units, five residential-sales units, five residential-property-management units and three electives: 18 units total. This is role-specific training alongside registration and supervised experience; it is not a separate national packaging rule.
NSW — Real estate agent licence (source record 2026-10-08) · National Training Register — CPP41419 (source record 2026-10-08) · National Training Register — CPP41419 Release 3 unit grid (source record 2026-10-13)
What exact map is still missing?
The retained NSW material does not name the full three-elective code-and-title schedule for the usual unrestricted Class 2 selection. Ask NSW Fair Trading and the provider for the exact 18-unit map, core/elective status and group membership before enrolling.
NSW — Real estate agent licence (source record 2026-10-08) · ASQA — Choose a course and provider (source record 2026-10-08)
What should you ask before choosing training?
- Which New South Wales authority matches the duties I plan to perform?
- Can I get a written unit-by-unit map, with core/elective status and qualification outcome?
- Which parts of this pathway remain subject to regulator or provider confirmation?